| 000 | 00864 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518035239.0 | ||
| 264 | 0 | _c20200617 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(19)30250-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStirrups, Robert | |
| 245 | 0 | 0 |
_aIdelalisib and rituximab for chronic lymphocytic leukaemia. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _c06 2019 |
||
| 300 |
_ae294 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeukemia, Lymphocytic, Chronic, B-Cell |
| 650 | 0 | 4 | _aPurines |
| 650 | 0 | 4 | _aQuinazolinones |
| 650 | 0 | 4 | _aRituximab |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 20 _gno. 6 _gp. e294 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(19)30250-5 _zAvailable from publisher's website |
| 999 |
_c29639039 _d29639039 |
||